← Back to Clinical Trials
Recruiting NCT07434349

NCT07434349 Exercise Timing and Postprandial Glucose Responses

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07434349
Status Recruiting
Phase
Sponsor Technical University of Munich
Condition Exercise Timing
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2026-04-01
Primary Completion 2026-08

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Timed Endurance ExerciseNo Exercise Control

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2026-04-01 with a primary completion date of 2026-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This interventional crossover study examines the effect of exercise timing relative to meal intake on postprandial glucose responses in healthy, physically active young adults. Participants complete five experimental conditions involving endurance exercise performed before or after breakfast or dinner, as well as a non-exercise control condition, while wearing a continuous glucose monitoring device. Postprandial glucose responses are assessed for the three consecutive meals following each exercise session. Following morning exercise, outcomes are assessed after breakfast, lunch, and dinner on the same day. Following evening exercise, outcomes are assessed after dinner on the same day and after breakfast and lunch on the subsequent day. All meals are standardized and consumed at fixed clock times.

Eligibility Criteria

Inclusion Criteria: * Age 18 to 35 years * Body mass index 18.5 to 24.9 kg per square meter * Able to complete 45 minutes of continuous running at an intensity corresponding to 75 to 85 percent of maximal heart rate without stopping * Engages in regular endurance-type physical activity * Habitual waking times are compatible with the fixed breakfast time of 08:00 * Willing and able to comply with all study procedures, including standardized meals, exercise sessions, behavioral restrictions, and continuous glucose monitoring * For female participants: non-pregnant and using stable hormonal contraception for at least 3 months Exclusion Criteria: * Acute or chronic illness * Metabolic disorders or conditions associated with altered glucose or lipid metabolism * Use of medications known to interfere with glucose metabolism or study outcomes * Intolerance or allergy to components of the standardized study diets * Pregnancy or breastfeeding * Body mass index greater than or equal to 25 kg per square meter * Current or past eating disorder, or any medical condition or medication that could affect appetite regulation, glucose regulation, or make vigorous endurance exercise unsafe * Current smoking or use of nicotine-containing products

Contact & Investigator

Central Contact

Christoph Höchsmann, PD Dr.

✉ christoph.hoechsmann@tum.de

📞 +49 89 289 24488

Principal Investigator

Christoph Höchsmann, PD Dr.

PRINCIPAL INVESTIGATOR

Technical University of Munich

Frequently Asked Questions

Who can join the NCT07434349 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Exercise Timing. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07434349 currently recruiting?

Yes, NCT07434349 is actively recruiting participants. Contact the research team at christoph.hoechsmann@tum.de for enrollment information.

Where is the NCT07434349 trial being conducted?

This trial is being conducted at München, Germany.

Who is sponsoring the NCT07434349 clinical trial?

NCT07434349 is sponsored by Technical University of Munich. The principal investigator is Christoph Höchsmann, PD Dr. at Technical University of Munich. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology